HCA Healthcare Earnings Miss, Stock Tumbles

HCA Healthcares Q1 2026 earnings report missed on adjusted EBITDA, causing a significant drop in stock price. Despite matching revenue and earnings estimates, the $50 million shortfall in EBITDA overshadowed the positive results. The stock, which is not typically this volatile, fell by 8.7% in afternoon trading. However, HCA provided strong full-year guidance, projecting earnings per share above consensus and EBITDA, which helped ease some worries. Despite the recent dip, a $1,000 investment in HCA over five years would now be worth $2,160, demonstrating the companys long-term strength. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/df6b42492cc50f1f